Choi Hee-nam has taken on his new role as the CEO of Chong Kun Dang Holdings, as his appointment was confirmed at the shareholders meeting and the board of directors of the pharmaceutical company at the end of last month.
Healis Therapeutics asset CKDB-501A shares Phase III topline results for glabellar injections from CKD Bio in South Korea streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
South Korean consortium to make 500 million doses of Sputnik V vaccine
By (0)
South Korean biomedical firms and the Russian Direct Investment Fund are in discussions for the production of Sputnik V vaccines in Korea for export. File Photo by RDIF/EPA-EFE
Feb. 25 (UPI) A consortium of South Korean biomedical companies is to manufacture Russia s Sputnik V vaccine.
Industry sources in Korea said the consortium that includes firms Binex, ISU Abxis, Boryung Biopharma, Chong Kun Dang Bio, Quratis, Humendix and Andong Animal Cell Validation Support Center are in negotiations with the Russian Direct Investment Fund over specific production quantities and prices, South Korean news service EDaily reported Thursday.